MCAULAY CAMERON (Chief Financial Officer) exercised options at TRANSPHORM, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 7/25/2023ACC: 0001209191-23-043342
Officer· Chief Financial Officer
Since Feb 2020
-33.84K
Net shares
Net seller
$10.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
3.03K acquired · 36.87K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.03K
Price / share
$3.30
Trade value
$10K
% of position
3.7%
7/21/2023
81.60K→84.63K
Total
Net shares
+3.03K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/21/2023 | M · Option Exercise | +3.03K | $3.30 | $10K | 3.7% | 81.60K | 84.63K |
| Total | +3.03K | $10K | ||||||
Derivative Transactions1
Subscription Rights (right to buy)
Direct
Converts to
Common Stock
3.03K shares
Shares
−36.87K
Strike price
3.30
Held after
0.00
Exercisable
—
7/21/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Subscription Rights (right to buy) Direct | Common Stock3.03K shares | 7/21/2023 | M · Option Exercise | −36.87K | 3.30 | — | 0.00 |